@inbook{f2ba160dbb31488e8a23d23bb6a1dc9f,
title = "The Role of Gemcitabine in Combined Modality Therapy",
author = "Jerome Landry and William Blackstock and MacRae, \{Robert M.\} and Yang, \{Gary Y.\} and Hak Choy",
note = "Part of the Cancer Drug Discovery and Development book series (CDDD) Gemcitabine is a novel pyrimidine nucleoside analog with a broad spectrum of clinical antitumor activity. In addition to its initial approved indication in pancreatic carcinoma, gemcitabine has been licensed for the treatment of nonsmall-cell lung cancer (NSCLC) (1).",
year = "2003",
month = jan,
day = "1",
doi = "10.1007/978-1-59259-325-5\_6",
language = "American English",
isbn = "978-1-58829-028-1",
series = "Cancer Drug Discovery and Development",
publisher = "Humana Totowa",
pages = "105--126",
booktitle = "Chemoradiation in Cancer Therapy",
}